Biological Seed Treatment Market To Witness Rapid Growth Due To Increasing Use In Commercial Crop Production
Biological seed treatment involves treating seeds with various microorganisms to enhance seed germination and protect seeds and seedlings from diseases. These treatments help support plant health from emergence and early growth through to mature crop. The microorganisms used include bacteria, fungi and other materials that occupy the seed surface, preventing pathogens from gaining a foothold. Some examples of biological seed treatments used in commercial production include rhizobia for legumes, mycorrhizal fungi to help roots absorb water and nutrients, and Trichoderma fungi to activate plant defenses against disease.
The global biological seed treatment market is estimated to be valued at US$ 1366.86 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing use of commercial crop seeds in agriculture is a key driver propelling the biological seed treatment market growth. Commercial crop seeds have higher yields and are economically important for farmers. However, they also have higher risks of diseases and need protection to realize their yields. Biological seed treatments help protect commercial seeds and seedlings during germination and early growth stages. This helps maximize crop establishment and improve productivity. Another driver is the rising preference for organic and environment-friendly farming practices globally. Biological seed treatments are plant-derived and environment-friendly alternatives to chemical-based treatments. They help support sustainable agriculture with natural crop protection methods. This increasing shift towards sustainable farming practices is fueling adoption of biological seed treatments.
SWOT Analysis
Strength: Biological seed treatment is an eco-friendly and sustainable solution for increasing crop yields. It enhances the plant's natural defense mechanisms against diseases and pests without any chemical residues. It promotes faster germination and improved root development in seeds. Biological seed treatments activate beneficial microbial communities in the soil that nourish the plant throughout its lifecycle.
Weakness: Biological seed treatments require careful handling and storage to maintain the viability of living microorganisms. Their effects are not as immediate as chemical pesticides and may require several growing seasons to build up soil microbiology. Adoption among conventional farmers requires education about alternative methods.
Opportunity: Increasing consumer demand for organic and chemical-free food creates a potential market for naturally treated agricultural produce. Biocontrols provide opportunities for farmers to reduce input costs by replacing synthetic agrochemicals. Growing awareness about environmental and health impacts of pesticide overuse boosts interest in sustainable agricultural solutions.
Threats: Strict regulation and lack of policy support in some nations can limit commercial access and affordability of biocontrol products. Rapid evolution of pest and disease resistance challenges the long-term efficacy of any single biological treatment. Weather fluctuations and natural disasters may disrupt microbial balance in soils affecting product performance.
Key Takeaways
The global Biological Seed Treatment Market Demand is expected to witness high growth. The global biological seed treatment market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Regional analysis shows that North America currently dominates the market due to growing organic farming and widespread adoption of integrated pest management programs. The Europe region follows in terms of market share and is projected to grow at a significant rate during the forecast period supported by government initiatives and regulations restricting chemical pesticide usage.
Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet. Product development and collaborations to introduce new formulations suitable for diverse crop types are key strategies adopted by these players to gain market share.
Explore more related article on this topic: https://www.ukwebwire.com/the-global-biological-seed-treatment-market/
Explore more related articles: https://lotstoexpress.com/whispers-of-the-genomics-exploring-the-secrets-hidden-in-every-stand/
https://blogger-veritas.blogspot.com/2024/01/the-global-medical-probiotics-market.html
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian